Photo of C. Warren Olanow

C. Warren Olanow

  • PROFESSOR Neurology
  • PROFESSOR Neuroscience
Print ProfilePrint Profile

Specialty

Certifications

  • Neurological Surgery

Clinical Focus

Education

  • MD, University of Toronto

  • Residency, Internal Medicine
    Toronto General Hospital

  • Residency, Internal Medicine
    Queen's Medical Center

  • Residency, Neurology
    Toronto General Hospital

  • Residency, Neurology
    Columbia-Presbyterian Medical Ctr.

  • Fellowship, Neuro Anatomy
    Columbia-Presbyterian Medical Ctr.

Biography

    C. Warren Olanow, M.D., FRCPC, is the Henry P. and Georgette Goldschmidt Professor and Chairman Emeritus of the Department of Neurology and Professor of Neuroscience at the Mount Sinai School of Medicine. He received his medical degree from the University of Toronto, performed his neurology training at the New York Neurological Institute at Columbia University, and did post-graduate studies in neuroanatomy at Columbia University.

    Dr. Olanow has served on the faculties of McGill University, Duke University, and the University of South Florida prior to joining Mount Sinai. He has authored more than 300 publications primarily related to Parkinson's disease and neurodegeneration.  He is the past President of the Movement Disorder Society, past Treasurer of the American Neurological Association, and former President of the International Society of Motor Disturbances.  He has been named an Honorary Professor at the University of London (Royal Free Hospital), and an Honorary Member of the French Neurological Society. Dr. Olanow serves on the Board of Directors of the National Space Biomedical Research Institute (a NASA consortium). He ranked #1 in the U.S. (#4 in the world) in research citations in Parkinson's disease during the past decade. Dr. Olanow has served on numerous editorial and scientific advisory boards and has lectured at universities and conferences throughout the world.

    In the News

    Dr. Olanow discusses Parkinson's Disease in The Daily News feature The Daily Check Up.
    View the PDF.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Olanow during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

  • Clintrex; Eli Lilly and Company; Novartis; Teva Pharmaceutical Industries Ltd.

Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:

  • Clintrex

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Clintrex

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Faculty Practice Associates Floor 7th Floor
5 East 98th Street
New York, NY 10029

Tel: 212-241-8435
Fax: 646-537-9690
Movement Disorders Center

5 East 98th Street
1st Floor
New York, NY 10029

Tel: 212-241-8435
Fax: 646-537-9690
Get Directions

Office Hours:
  • Tuesday 9:00am - 1:00pm